Julien Gander

Julien Gander serves as the EVP and Group General Counsel at Idorsia Pharmaceuticals Ltd since November 2022, following a tenure as General Counsel and Senior Vice President Legal at Molecular Partners from July 2016 to November 2022. Previously, Julien held various legal roles at Lonza from May 2012 to May 2016, including Director Legal & Group Risk Management and Secretary of the Board of Directors. Julien began a legal career as an Associate at Homburger and the Swiss Competition Commission. Education includes a Master of Laws (LL.M.) from the University of Cambridge and a Master of Laws (LLM) from the University of Fribourg, along with completion of the Bar Examination in the Canton of Bern. Expertise encompasses corporate law, financing, stock exchange, M&A, contracts, employment, and environmental law.